David O Reilly (@davidoreilly2) 's Twitter Profile
David O Reilly

@davidoreilly2

Medical Oncologist, Clinical Research Fellow/PhD Candidate @ Beaumont RCSI Cancer Centre

ID: 285747810

calendar_today21-04-2011 18:21:24

131 Tweet

453 Followers

663 Following

Jarushka Naidoo (@drjnaidoo) 's Twitter Profile Photo

IASLC #WCLC2025 is upon us! Your co-chairs cannot wait to welcome you Noemi Reguart🇪🇸 Isabelle Opitz🇨🇭 Umberto Malapelle🇮🇹 & Jarushka Naidoo🇮🇪 Registration & abstract submissions are OPEN! Join us in Barcelona | Sept 6–9, 2025 IASLC OncoAlert #LCSM bit.ly/IASLCWCLC  #WCLC25

IASLC #WCLC2025 is upon us! Your co-chairs cannot wait to welcome you <a href="/NReguart/">Noemi Reguart</a>🇪🇸 <a href="/IsaOpitz/">Isabelle Opitz</a>🇨🇭 <a href="/UmbertoMalapel1/">Umberto Malapelle</a>🇮🇹 &amp; <a href="/DrJNaidoo/">Jarushka Naidoo</a>🇮🇪 

Registration &amp; abstract submissions are OPEN! 

Join us in Barcelona | Sept 6–9, 2025 
<a href="/IASLC/">IASLC</a> <a href="/Oncoalert/">OncoAlert</a> #LCSM bit.ly/IASLCWCLC  #WCLC25
Yvonne Diaz (@yvonne_diaz_) 's Twitter Profile Photo

Professor Jarushka Naidoo welcomed to the #BTOG25 stage as a Lung Cancer Legend by Dr Gerard Walls & doesn’t disappoint. Lots of discussion on how we turn discussions on Small Cell Lung Cancer on its head. Lots of optimism in #SCLC coming from new standards & future treatments. #LCSM

Professor <a href="/DrJNaidoo/">Jarushka Naidoo</a> welcomed to the #BTOG25 stage as a Lung Cancer Legend by Dr <a href="/gwalls89/">Gerard Walls</a> &amp; doesn’t disappoint. Lots of discussion on how we turn discussions on Small Cell Lung Cancer on its head. Lots of optimism in #SCLC coming from new standards &amp; future treatments. #LCSM
David O Reilly (@davidoreilly2) 's Twitter Profile Photo

Fascinating session exploring MCED testing - Methylation based assays sensitivities = 25% in early stage disease - Validation in prospective clinical trials needed - Positive MCED test likely prognostic in advanced disease

Fascinating session exploring MCED testing
- Methylation based assays sensitivities = 25% in early stage disease
- Validation in prospective clinical trials needed
- Positive MCED test likely prognostic in advanced disease
David O Reilly (@davidoreilly2) 's Twitter Profile Photo

Fascinating session exploring MCED testing - A positive MCED test is likely prognostic in advanced diseaze - Prospective evaluation in clinical trials is essential - Patients need prompt and accurate results ASCO

Fascinating session exploring MCED testing
- A positive MCED test is likely prognostic in advanced diseaze
- Prospective evaluation in clinical trials is essential
- Patients need prompt and accurate results
<a href="/ASCO/">ASCO</a>
David O Reilly (@davidoreilly2) 's Twitter Profile Photo

Special thanks to NECRET NorthEast Cancer Research & Education Trust who provide vital funding for oncology translational research in the North East which is much appreciated and essential for ongoing exhaled breath works